Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 5/20 | 0.41 |
| ▸ | DNPEP | Q9ULA0 | 4/20 | 0.41 |
| ▸ | RNPEP | Q9H4A4 | 4/20 | 0.38 |
| ▸ | LAP3 | P28838 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.33 |
| ▸ | RAB9A | P51151 | 3/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.32 |
| ▸ | MMP8 | P22894 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 2/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dichloroacetic Acid SCHEMBL11694552 | 0.87 | ANPEP (0.40) | ANPEPDNPEPRNPEPLAP3SMN1; SMN2 | |
| Dichloroacetic Acid SCHEMBL11698922 | 0.87 | ANPEP (0.40) | ANPEPDNPEPRNPEPLAP3SMN1; SMN2 | |
| SCHEMBL3948235 | 0.82 | — | — | |
| SCHEMBL27400015 | 0.81 | TSHR (0.34) | — | |
| Hydrochloric Acid SCHEMBL31026689 | 0.80 | ANPEP (0.41) | ANPEPDNPEPRNPEPLAP3ALDH1A1 | |
| SCHEMBL674969 | 0.79 | MEN1 (0.32) | CYP1A2SMN1; SMN2 | |
| SCHEMBL26254720 | 0.79 | ANPEP (0.34) | ANPEPDNPEPRNPEPALDH1A1CYP1A2 | |
| SCHEMBL4100175 | 0.78 | CYP2D6 (0.39) | CYP2C19MMP8 | |
| Hydrochloric Acid SCHEMBL11134107 | 0.77 | CYP2D6 (0.38) | CYP2C19MMP8 | |
| Hydrochloric Acid SCHEMBL27326502 | 0.77 | CYP2D6 (0.38) | CYP2C19MMP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10344002-B2 | Compositions and methods for treating metabolic disorders | NUSIRT SCIENCES, INC. (US) | 2019-07-09 | — | — | US | disclosed |
| US-20180105498-A1 | COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISORDERS | NUSIRT SCIENCES, INC. | 2018-04-19 | — | — | US | disclosed |
| US-20180105498-A1 | COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISORDERS | NUSIRT SCIENCES, INC. | 2018-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10344002-B2 | Compositions and methods for treating metabolic disorders | LIPC, PC, PNLIP | ANPEP 1910/4885DNPEP 1085/4885RNPEP 1081/4885 |
| US-20180105498-A1 | COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISORDERS | LIPC, PC, PNLIP | ANPEP 1910/4885DNPEP 1085/4885RNPEP 1081/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.